AU5141898A - Pharmaceutical lipid aggregate with helicobacter pylori antigen and negatively charged lipid - Google Patents
Pharmaceutical lipid aggregate with helicobacter pylori antigen and negatively charged lipidInfo
- Publication number
- AU5141898A AU5141898A AU51418/98A AU5141898A AU5141898A AU 5141898 A AU5141898 A AU 5141898A AU 51418/98 A AU51418/98 A AU 51418/98A AU 5141898 A AU5141898 A AU 5141898A AU 5141898 A AU5141898 A AU 5141898A
- Authority
- AU
- Australia
- Prior art keywords
- lipid
- negatively charged
- helicobacter pylori
- pharmaceutical
- pylori antigen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/543—Lipids, e.g. triglycerides; Polyamines, e.g. spermine or spermidine
- A61K47/544—Phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Dispersion Chemistry (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9604296 | 1996-11-22 | ||
SE9604296A SE9604296D0 (en) | 1996-11-22 | 1996-11-22 | New pharmaceutical formulation of polypeptides |
PCT/SE1997/001927 WO1998022135A1 (en) | 1996-11-22 | 1997-11-18 | Pharmaceutical lipid aggregate with helicobacter pylori antigen and negatively charged lipid |
Publications (1)
Publication Number | Publication Date |
---|---|
AU5141898A true AU5141898A (en) | 1998-06-10 |
Family
ID=20404716
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU51418/98A Abandoned AU5141898A (en) | 1996-11-22 | 1997-11-18 | Pharmaceutical lipid aggregate with helicobacter pylori antigen and negatively charged lipid |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU5141898A (en) |
SE (1) | SE9604296D0 (en) |
WO (1) | WO1998022135A1 (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6207646B1 (en) | 1994-07-15 | 2001-03-27 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
AU783344B2 (en) * | 1999-02-17 | 2005-10-20 | Csl Limited | Immunogenic complexes and methods relating thereto |
GB0008877D0 (en) * | 2000-04-12 | 2000-05-31 | Astrazeneca Ab | Polypeptide delivery system |
GB0008879D0 (en) * | 2000-04-12 | 2000-05-31 | Astrazeneca Ab | Polypeptide delivery system |
GB0010371D0 (en) * | 2000-04-29 | 2000-06-14 | Astrazeneca Ab | Helicobacter pylori antigens |
US11197916B2 (en) | 2007-12-28 | 2021-12-14 | Takeda Pharmaceutical Company Limited | Lyophilized recombinant VWF formulations |
BRPI0821474B8 (en) | 2007-12-28 | 2021-05-25 | Baxalta GmbH | stable liquid pharmaceutical formulation |
EP2344152A4 (en) * | 2008-10-08 | 2013-04-03 | Immune Solutions Ltd | Oral vaccines for producing mucosal immunity |
TWI508735B (en) | 2008-10-21 | 2015-11-21 | 巴克斯特國際公司 | Lyophilized recombinant vwf formulations |
KR20180096643A (en) * | 2015-12-14 | 2018-08-29 | 테크니쉐 유니베르시테트 뮌헨 | Helicobacter pylori vaccine |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5643574A (en) * | 1993-10-04 | 1997-07-01 | Albany Medical College | Protein- or peptide-cochleate vaccines and methods of immunizing using the same |
-
1996
- 1996-11-22 SE SE9604296A patent/SE9604296D0/en unknown
-
1997
- 1997-11-18 WO PCT/SE1997/001927 patent/WO1998022135A1/en active Application Filing
- 1997-11-18 AU AU51418/98A patent/AU5141898A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
SE9604296D0 (en) | 1996-11-22 |
WO1998022135A1 (en) | 1998-05-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU4397297A (en) | Antibody against human parathormone related peptides | |
AU8766098A (en) | Assay methods and apparatus | |
AU5744696A (en) | In situ immunodetection of antigens | |
AU8780998A (en) | Visual inspection and verification system | |
AU2829995A (en) | Detection of helicobacter pylori | |
HUP9901546A3 (en) | Helicobacter pylori antigens and vaccine compositions | |
AU2705395A (en) | Fas associated proteins | |
AU7422496A (en) | NM03 antibody materials and methods | |
AU3159499A (en) | Antigen preparation and use | |
AU3199897A (en) | Immunstimulating lipid formulation | |
AU5141898A (en) | Pharmaceutical lipid aggregate with helicobacter pylori antigen and negatively charged lipid | |
AU5874798A (en) | Vaccination methods and molecules | |
HUP0100192A3 (en) | Improved stomach-action molluscicides and preparation thereof | |
EP0821698A4 (en) | Protective helicobacter antigens | |
AU6322598A (en) | Case for combustible materials and methods for making and using the same | |
AU5160596A (en) | Helicobacter pylori cagi region | |
AU7238098A (en) | Peptides having cyclic structures and exerting p53 protein activty-restoring effect on p53 protein mutants | |
AU1538497A (en) | Anti-gp46 antibodies and fragments thereof and their use | |
EP0725139A3 (en) | Recombinant prostate-specific antigen and its use as an immunoassay calibrator | |
AU7572198A (en) | Tumor-associated antigen | |
AU3657995A (en) | Helicobacter lactoferrin receptor | |
AU5125698A (en) | Stabilized pharmaceutical compositions based on quinupristine and on dalfopristine and their preparation | |
AU5528198A (en) | Vaccination and methods against multiple sclerosis using specific tcr vbeta peptides | |
AU7711096A (en) | Cisplatinum comprising pharmaceutical | |
AUPP363498A0 (en) | Antigens and their detection |